Royce Micro-Cap Trust, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Francis G. Waltman
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- One Madison Avenue New York NY United States of America 10010
- IPO Date
- Dec 14, 1993
- CIK
- 0000912147
- Website
- roycefunds.com
- Similar Companies
- Business
- Royce Micro-Cap Trust, Inc. is a closed-end diversified management investment company focused on long-term capital appreciation through investments primarily in equity securities of micro-cap companies, defined generally as those with market capitalizations of $1 billion or less at the time of investment. The Trust invests across a broad range of industries with significant holdings in industrials; information technology; financials; health care; consumer discretionary; consumer staples; energy; and materials sectors. The portfolio employs a core investment approach combining multiple themes to provide wide exposure to micro-cap stocks with strong fundamentals and growth prospects. The Trust seeks to invest predominantly in U.S.-based micro-cap companies, with approximately 17% of assets allocated to non-U.S. investments as part of its diversified portfolio. It benchmarks performance primarily against the Russell Microcap and Russell 2000 indices, reflecting its focus on smaller capitalization enterprises. Royce Micro-Cap Trust was founded in 1993 and is headquartered in New York, New York. The Trust's main products and services include actively managed portfolios of publicly traded micro-cap equity securities; its offering is aimed at investors seeking access to smaller, under-followed companies with potential for capital appreciation. It operates a disciplined, research-driven methodology overseen by Royce & Associates, LLC, which manages the Trust. The Trust also provides income distributions, with a recent distribution policy targeting a 7% annual payout based on a rolling average of net asset values, emphasizing current income alongside growth. Recent major developments include the implementation of a distribution policy with quarterly payouts on common stock, including a $0.24 per share distribution declared for the fourth quarter of 2025. The Trust has maintained its focus on portfolio diversification and risk management while continuing to outperform its benchmarks over multiple long-term periods, reflecting steady operational stability. It has seen consistent portfolio turnover around 53% for 2024 and sustained net assets exceeding $600 million. There have been no recent name changes or reorganizations, but the company actively updates prospectuses and maintains adherence to regulatory compliance and shareholder communication standards. Royce Micro-Cap Trust operates primarily in the asset management and financial services sectors, targeting institutional and retail investors globally but with a geographic concentration in the United States. Its portfolio emphasizes investments in micro-cap companies that demonstrate strong growth potential and resilient fundamentals, making it a niche player in the closed-end fund universe dedicated to the micro-cap market segment. The Trust is listed on the NYSE under the ticker RMT. Overall, Royce Micro-Cap Trust delivers access to the micro-cap equity market through its actively managed fund structure, combining capital appreciation focus with income distribution, supported by Royce’s expert management team and established multi-decade track record in micro-cap investing. The firm continues to balance growth opportunities with income generation for its investors across its diversified, multi-sector portfolio.
RMT: Micro-Caps Are On Fire! Collect Income From The Growth
RMT: Micro Caps With A 6% Yield, 12% Discount
Royce Micro-Cap Trust (NYSE: RMT) as of May 31, 2026
Resolution Therapeutics extends inflammatory and fibrotic disease pipeline with in vivo Regenerative Macrophage Therapy
Royce Micro-Cap Trust, Inc. (NYSE-RMT) declares Second Quarter Common Stock Distribution of $0.21 Per Share
Royce Micro-Cap Trust, Inc. (NYSE-RMT) declares Second Quarter Common Stock Distribution of $0.21 Per Share
Royce Micro-Cap Trust (NYSE: RMT) as of Apr 30, 2026
Royce Micro-Cap Trust (NYSE: RMT) as of Apr 30, 2026
Resolution Therapeutics to showcase key preclinical data on its Regenerative Macrophage Therapy (RMT) RTX001 in oral presentation at ASGCT 2026
Royce Micro-Cap Trust (NYSE: RMT) as of Mar 31, 2026
Royce Micro-Cap Trust (NYSE: RMT) as of Feb 28, 2026
Royce Micro-Cap Trust: What Worked
Royce Micro-Cap Trust, Inc. (NYSE-RMT) declares First Quarter Common Stock Distribution of $0.19 Per Share
Royce Micro-Cap Trust (NYSE: RMT) as of Jan 31, 2026
Royce Micro-Cap Trust (NYSE: RMT) as of Dec 31, 2025
RMT: An 8% Plus Yield, 12% Discount, And Exposure To Micro-Cap Equity Space
Royce Micro-Cap Trust (NYSE: RMT) as of Nov 30, 2025
Royce Micro-Cap Trust, Inc. (NYSE-RMT) declares Fourth Quarter Common Stock Distribution of $0.24 Per Share
Advisors Asset Management Inc. Sells 143,676 Shares of Royce Otc Micro $RMT
Royce Micro-Cap Trust (NYSE: RMT) as of Oct 31, 2025